We previously demonstrated that angiopoietin‐like protein 2 (ANGPTL2) promotes tumor progression using a Xp11.2 translocation renal cell carcinoma (tRCC) mouse model. Here, ANGPTL2 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.